![Cisapride tartrate [189888-25-3] Cisapride tartrate [189888-25-3]](https://www.targetmol.com/group3/M00/02/A9/CgoaEWY7NJaEMKVyAAAAALWIhi4679.png)
Cisapride tartrate [189888-25-3]
T70070
Molecular Weight616.04
Product group Chemicals
Overview
- SupplierTargetMol Chemicals
- Product NameCisapride tartrate [189888-25-3]
- Delivery Days Customer72
- CertificationResearch Use Only
- Chemical NameCisapride tartrate
- Molecular FormulaC27H35ClFN3O10
- Molecular Weight616.04
- Scientific DescriptionCisapride tartrate is chemically related to metoclopramide, but unlike metoclopramide, it does not cross the blood-brain barrier or have antidopaminergic effects. Cisapride is a serotonin-4 (5-HT4) receptor agonist. Cisapride was indicated for the symptomatic treatment of adult patients with nocturnal heartburn due to gastroesophageal reflux disease. The Food and Drug Administration (FDA) in America stopped the marketing of cisapride as of 14th July 2000. They had received at least 341 reports of heart rhythm abnormalities and these led to 80 deaths. Other reported adverse effects are: headache, diarrhea, abdominal pain, nausea, constipation. Cisapride for animals has been found helpful in some cases of megaesophagus and is a common treatment for feline megacolon. Clarithromycin, erythromycin, and troleandomycin markedly inhibit the metabolism of cisapride. Concurrent administration of certain anticholinergic compounds, such as belladonna alkaloids and dicyclomine, would be e......
- Shelf life instruction3 years
- SMILESO[C@H]([C@@H](O)C(O)=O)C(O)=O.CO[C@H]1CN(CCCOc2ccc(F)cc2)CC[C@H]1NC(=O)c1cc(Cl)c(N)cc1OC
- Storage Instruction-20°C
- UNSPSC12352200